Evidence map›Paper›PMID 31073164›Full record

ArticleNature communications2019

Sox17 is required for endothelial regeneration following inflammation-induced vascular injury.

Menglin Liu, Lianghui Zhang, Glenn Marsboom, Ankit Jambusaria, Shiqin Xiong, Peter T Toth, Elizaveta V Benevolenskaya, Jalees Rehman, Asrar B Malik

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.

  1. Lipedema: Progress, Challenges, and the Road Ahead.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Decreased Production of Tissue Plasminogen Activator in Endothelial Cells From Nasal Polyps.World journal of otorhinolaryngology - head and neck surgery · 2026
    Article
  8. CXCR1 Depletion in Ly6CAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. SOX17 in pulmonary arterial hypertension: from development to clinical phenotype.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Hypoxia regulate developmental coronary angiogenesis potentially through VEGF-R2- and SOX17-mediated signaling.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Article
  19. Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Menglin LiuDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA.
Lianghui ZhangDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA.
Glenn MarsboomDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA.
Ankit JambusariaDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA.
Shiqin XiongDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA.
Peter T TothDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA.
Elizaveta V BenevolenskayaDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA.ORCID http://orcid.org/0000-0003-3573-1754
Jalees RehmanDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA. jalees@uic.edu.ORCID http://orcid.org/0000-0002-2787-9292
Asrar B MalikDepartment of Pharmacology, The University of Illinois College of Medicine, Chicago, IL, 60612, USA. abmalik@uic.edu.
Illinois College · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
TRAINING PROGRAM IN LUNG BIOLOGY AND PATHOBIOLOGYT32HL007829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOLLY MEHTA · 1995 to 2026
$15.6M
THROMBIN-INDUCED PULMONARY VASCULAR PERMEABILITYR01HL045638 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KOMAROVA, YULIA A · 1991 to 2025
$12.0M
Mesenchymal-Endothelial Transition as a Homeostatic Regenerative Mechanism in Acute Lung InjuryR01HL090152 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B., REHMAN, JALEES · 2007 to 2019
$5.9M
Endothelial Regeneration Following Lung Vascular InjuryR01HL118068 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B., REHMAN, JALEES · 2014 to 2017
$2.4M
Role of KDM5A in pRB-mediated differentiationR01CA211095 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BENEVOLENSKAYA, ELIZAVETA V · 2017 to 2021
$1.8M
American Heart Association (American Heart Association, Inc.) 18CDA34110068NCI NIH HHS R01 CA211095NHLBI NIH HHS P01 HL060678NHLBI NIH HHS R01 HL045638NHLBI NIH HHS R01 HL090152NHLBI NIH HHS R01 HL118068NHLBI NIH HHS T32 HL007829U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) P01-HL60678U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01-HL118068U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01-HL45638U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01-HL90152U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) T32-HL007829
6 · The paper itself

Abstract

Repair of the endothelial cell barrier after inflammatory injury is essential for tissue fluid homeostasis and normalizing leukocyte transmigration. However, the mechanisms of endothelial regeneration remain poorly understood. Here we show that the endothelial and hematopoietic developmental transcription factor Sox17 promotes endothelial regeneration in the endotoxemia model of endothelial injury. Genetic lineage tracing studies demonstrate that the native endothelium itself serves as the primary source of endothelial cells repopulating the vessel wall following injury. We identify Sox17 as a key regulator of endothelial cell regeneration using endothelial-specific deletion and overexpression of Sox17. Endotoxemia upregulates Hypoxia inducible factor 1α, which in turn transcriptionally activates Sox17 expression. We observe that Sox17 increases endothelial cell proliferation via upregulation of Cyclin E1. Furthermore, endothelial-specific upregulation of Sox17 in vivo enhances lung endothelial regeneration. We conclude that endotoxemia adaptively activates Sox17 expression to mediate Cyclin E1-dependent endothelial cell regeneration and restore vascular homeostasis.

Indexed as

AnimalsCell DifferentiationCell LineCell ProliferationCyclin EDisease Models, AnimalEndothelial CellsEndothelium, VascularEndotoxemiaHEK293 CellsHMGB ProteinsHumansHypoxia-Inducible Factor 1, alpha SubunitLipopolysaccharidesMiceMice, Inbred C57BLCCNE1 protein, humanCyclin Ecyclin E1, mouseHIF1A protein, humanHif1a protein, mouseHMGB ProteinsHypoxia-Inducible Factor 1, alpha SubunitLipopolysaccharidesOncogene ProteinsSOX17 protein, humanSox17 protein, mouseSOXF Transcription Factors

Identifiers

PMID31073164
PMCPMC6509327
OpenAlexW2944372903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.